Sickle cell disease trials in Nigeria

In Nigeria 9 Also abroad 204

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Hydroxyurea Optimisation in Sickle Cell Disease
Where
Ile-Ife
Age
18 years and over
People
100
Run by
Ochuko Orherhe
See details and how to joinNCT07543289
Phase 2Taking people
A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
Where
Ituku-Ozalla, Lagos, Tarauni
Age
6 months to 18 years
People
95 worldwide
Run by
Forma Therapeutics, Inc.
See details and how to joinNCT06198712 · EU 2024-519881-32-00
Phase 3Taking people
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Where
Abuja, Ibadan, Ituku-Ozalla, Kaduna, Kano, Lagos
Age
2 years and over
People
480 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00
Phase 3Taking people
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Where
Abuja, Ibadan, Ituku-Ozalla, Lagos
Age
12 years and over
People
510 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06612268 · EU 2023-509175-16-00
Phase 2Taking people
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
Where
Ibadan, Lagos, Tarauni
Age
12 years to 16 years
People
27 worldwide
Run by
Forma Therapeutics, Inc.
See details and how to joinNCT05953584
Phase 2/3Taking people
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Where
Ibadan, Kano, Lagos
Age
12 years to 64 years
People
389 worldwide
Run by
Pfizer
See details and how to joinNCT05431088 · EU 2023-508766-14-00
No phaseTaking people
mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria
Where
Abuja
Age
12 months and over
People
900
Run by
New York University
See details and how to joinNCT06318143
Phase 4Taking people
Stroke Prevention in Nigeria 2 Trial
Where
Kano
Age
5 years to 12 years
People
220
Run by
Vanderbilt University Medical Center
See details and how to joinNCT06526117
No phaseTaking people
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Where
Abuja, Kaduna, Zaria
Age
2 years and over
People
30,000 worldwide
Run by
Cyprus Institute of Neurology and Genetics
See details and how to joinNCT05799118